HFCAS OpenIR

浏览/检索结果: 共3条,第1-3条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2021, 卷号: 10
作者:  Tong, Ying-Hui;  Hu, Xiao-Ping;  Xiang, Xue-Ping;  Fang, Luo
收藏  |  浏览/下载:40/0  |  提交时间:2021/05/17
Monocarboxylate transporter 1 (MCT1)  monocarboxylate transporter 4 (MCT4)  prognosis  non-small cell lung cancer (NSCLC)  
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun;  Xu, Weizhen;  Shao, Yang;  Yu, Xinmin;  Jin, Ying
收藏  |  浏览/下载:44/0  |  提交时间:2020/10/26
tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)  
Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers 期刊论文
ONCOTARGETS AND THERAPY, 2020, 卷号: 13
作者:  Ma, De-Ning;  Gao, Xin-Yi;  Dan, Yi-Bo;  Zhang, An-Ni;  Wang, Wei-Jun;  Yang, Guang;  Zhu, Hong-Zhou
收藏  |  浏览/下载:39/0  |  提交时间:2020/11/26
radiogenomics  SVM  non-small cell lung cancer  anaplastic lymphoma kinase  epidermal growth factor receptor